EdiTy Therapeutics For Profit
Edity Therapeutics - Cellular Re-programming utilizing the Immune system: We use immune cells to deliver protein directly to the cytoplasm of diseased cells to improve patient health and longevity.
Founded Date:
2020-01-01
Headquarters:
Rehovot, HaMerkaz, Israel
Technology:
Stem cells
Employee Number:
11-50
Industry:
Regenerative Medicine